6.53 USD
▼+0.34-1.21%
盘后 6.67 +0.88%
2026-08-03
市值
$2.33B
市盈率
—
EPS
-1.17
股息率
—
52 周区间
1.70 – 6.70
成交量
8.02M
Beta
1.01
目标价
12.50
52W 低 1.7052W 高 6.70
价格走势
公司简介
Precigen, Inc.,a discovery and clinical-stage biopharmaceutical company, develops gene and cell therapies using precision technology to target diseases in areas of immuno-oncology, autoimmune disorders, and infectious diseases. The company offers therapeutic platforms consisting of AdenoVerse platform, which utilizes a library of proprietary adenovectors for gene delivery of therapeutic effectors, immunomodulators, and vaccine antigen; and UltraCAR-T to provide chimeric antigen receptor T cell therapies for cancer patients. It also develops pro...